VAERS 2413016
GLAXOSMITHKLINE BIOLOGICALS · ZOSTER (SHINGRIX) · Charge FAN5A
- Staat
- MO
- Alter
- -
- Geschlecht
- M
- Eingang
- 17.08.2022
- Impfdatum
- -
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- - / -
Symptomtext
Patient received only a partial dose as she lose some volume from the syringe during administration; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete dose administered in a elderly male patient who received Herpes zoster (Shingrix) (batch number FAN5A, expiry date 28th July 2023) for prophylaxis. On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete dose administered. On an unknown date, the outcome of the incomplete dose administered was unknown. Additional Information: GSK Receipt Date: 08-AUG-2022. Reporter's Comments: The patient received only a partial dose of Shingrix vaccine as she loses some volume from the syringe during administration. The consent to follow up was granted. Additional Supportive Information: As patient received only a partial dose of Shingrix, which led to incomplete dose administered.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -